Panel: AVM/DAVF

Friday, September 16, 2022

11:30 AM – 12:00 PM East Coast USA Time

Location: JW Grand Ballroom 4

CE: .5

Reference 1: De Leacy R, Ansari SA, Schirmer CM, et al Endovascular treatment in the multimodality management of brain arteriovenous malformations: report of the Society of NeuroInterventional Surgery Standards and Guidelines Committee Journal of NeuroInterventional Surgery Published Online First: 12 April 2022. doi: 10.1136/neurintsurg-2021-018632
Reference 2: 0
Reference 3: 0

Non-Member Speaker(s)

Maureen A. Darwal

Neurosurgeon
Thomas Jefferson University

Disclosure(s): No financial relationships to disclose

Slides

Member Speaker(s)

CL

Chine Logan, DO, MHA, MS, FACS, FACOS

Endovascular Neurosurgeon
Nashville Neurosurgical Associates

Disclosure(s): Republic Spine: Consultant (Terminated)
Calvin C. Whaley, DO

Endovascular Neurosurgeon
West Virginia Ortho Neuro

Disclosure(s): No financial relationships to disclose

Slides

Disclosure(s):

Maureen A. Darwal: No financial relationships to disclose

Chine Logan, DO, MHA, MS, FACS, FACOS: Republic Spine: Consultant (Terminated)

Calvin C. Whaley, DO: No financial relationships to disclose

Learning Objectives:

To understand the ARUBA trial as well as the criticms and flaws of the trial.
To elucidate treatment of unruptured arteriovenous malformations post ARUBA
To describe further directions in unruptured arteriovenous malformation research and patient management.